The following article is an Op Ed that appeared in today's print version of the San Francisco Chronicle Biotechnology was born in California in the 1970s based on the discovery out of one of its universities and California is responsible for an industry that has impacted the lives of billions of people worldwide. In 2004, … Continue reading California’s Stem Cell Agency Accelerates Treatments to Patients
Lou Gehrig’s Disease
Potential cell therapy for ALS
Imagine being told that you have a condition that gradually causes you to lose the ability to control your body movements, from picking up a pencil to walking to even breathing. Such is the reality for the nearly 6,000 people who are diagnosed with amyotrophic lateral sclerosis (ALS) every year, in the United States alone. … Continue reading Potential cell therapy for ALS
What makes an expert an expert?
When we launched our Facebook Live “Ask the Expert” series earlier this year we wanted to create an opportunity for people to hear from and question experts about specific diseases or disorders. The experts we turned to were medical ones, neurologists and neuroscientists in the case of the first two Facebook Live events, stroke and … Continue reading What makes an expert an expert?
ALS is in the spotlight in CIRM’s “Ask the Expert About ALS and Stem Cells” Facebook Live event
San Francisco 49ers Dwight Clark makes his iconic "Catch" against the Dallas Cowboys American Football great Dwight Clark was renowned for having the safest hands in the game while playing for the San Francisco 49ers. But in September 2015, he was diagnosed with ALS (also known as Lou Gehrig’s disease) after not being able to … Continue reading ALS is in the spotlight in CIRM’s “Ask the Expert About ALS and Stem Cells” Facebook Live event
Boosting immune system cells could offer a new approach to treating Lou Gehrig’s disease
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is one of those conditions that a lot of people know about but don’t know a lot about. If they are fortunate, it will stay that way. ALS is a nasty neurodegenerative disease that attacks motor neurons, the cells in the brain and spinal cord … Continue reading Boosting immune system cells could offer a new approach to treating Lou Gehrig’s disease
Straight to brain: A better approach to ALS cell therapies?
Getting the go ahead to begin a clinical trial by no means marks an end to a research team’s laboratory studies. A clinical trial is merely one experiment and is designed to answer a specific set of questions about a specific course of treatment. There will inevitably be more questions to pursue back in the … Continue reading Straight to brain: A better approach to ALS cell therapies?
Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
At CIRM we don’t have a disease hierarchy list that we use to guide where our funding goes. We don’t rank a disease by how many people suffer from it, if it affects children or adults, or how painful it is. But if we did have that kind of hierarchy you can be sure that … Continue reading Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
Using stem cells to fix bad behavior in the brain
Diseases of the brain have many different names, from Alzheimer’s and Parkinson’s to ALS and Huntington’s, but they often have similar causes. Researchers at the Gladstone Institutes in San Francisco are using that knowledge to try and find an approach that might be effective against all of these diseases. In a new CIRM-funded study, … Continue reading Using stem cells to fix bad behavior in the brain
Ingenious CIRM-funded stem cell approach to treating ALS gets go-ahead to start clinical trial
Amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig’s disease, was first identified way back in 1869 but today, more than 150 years later, there are still no effective treatments for it. Now a project, funded by CIRM, has been given approval by the Food and Drug Administration (FDA) to start a clinical trial that … Continue reading Ingenious CIRM-funded stem cell approach to treating ALS gets go-ahead to start clinical trial
A Dream made me change my mind. Almost.
Dream Alliance: photo courtesy Daily Telegraph, UK On Friday I was faced with the real possibility that a horse had made an ass out of me. Over the years we have written many articles about the risks of unproven stem cell therapies, treatments that have not yet been shown in clinical trials to be safe … Continue reading A Dream made me change my mind. Almost.